Anti‐TNF agents for rheumatoid arthritis [PDF]
British Journal of Clinical Pharmacology, 2001 Rheumatoid arthritis (RA) is a chronic inflammatory, autoimmune disease with a prevalence of approximately 1% and an annual incidence of 0.04%. Up to 50% of patients with RA are unable to work 10 years after diagnosis. The disease is associated with significant morbidity and mortality with associated medical costs to the UK of between £240 m and £600 m
Thomas, SHL +3 more
openaire +4 more sources
Mucosal Healing with Anti-TNF Antibodies [PDF]
Digestion, 2012 Nowadays, mucosal healing is regarded as a major end point in clinical trials and is increasingly used in clinical practice for the management of patients with inflammatory bowel disease. The definition of mucosal healing varies across studies and validated endoscopic scoring indices are still lacking.
Chevaux, Jean-Baptiste +5 more
openaire +2 more sources
Disease Markers, Volume 2018, Issue 1, 2018., 2018 Background. Alterations of the small‐intestinal permeability (s‐IP) might play an essential role in a subgroup of diarrhoea‐predominant IBS (D‐IBS) patients. Goals. (a) To analyse in D‐IBS patients the symptom profile in relation to the altered (+) or not (−) s‐IP using the Gastrointestinal Symptom Rating Scale (GSRS).
Francesco Russo +7 more
wiley +1 more source
Przeciwciała anty-PD-1 w leczeniu chorych na chłoniaki [PDF]
, 2022 The adaptive immune response influences the course of neoplastic diseases. Also, through the programmed cell death pathway with cytotoxic T lymphocytes carring the PD-1 receptor.
Paszkiewicz-Kozik, Ewa; Klinika Nowotworów Układu Chłonnego. Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie — Państwowy Instytut Badawczy w Warszawie +1 more
core
ANTY PANSERA, UNA STORICA TRA I TIPOGRAFI [PDF]
, 2021 Un'intervista ad Anty PAnsera affronta il tema del rappoerto tra cultura umanistica e tecnica, utilizzando come case study la sua permanenza nella redazione della rivista Graphicus negli anni ...
Elena DELLAPIANA
core
Changes in expression of TNF alpha and its receptors mRNAs in oocytes and granulosa cells in mice with experimental immune ovarian failure [PDF]
, 2014 Purpose: To investigate the expression of TNF- α and its receptors (types I and II) at mRNA level in oocytes and granulose cells as well as to study effect of TNF-α on follicular cell death in mice with experimental immune ovarian failure induced by ...
Grushka, Nataliya +4 more
core +1 more source
Mechanizm działania skojarzonej immunoterapii anty-CTLA-4 i anty-PD-1 u chorych na nowotwory
, 2023 Z uwagi na ograniczoną skuteczność immunoterapii stosowanej w monoterapii 1. linii leczenia chorych na różne typy nowotworów, powstały koncepcje łączenia różnych metod immunoterapii.
Krawczyk, Paweł; Katedra i Klinika Pneumonologii, Onkologii i Alergologii Uniwersytetu Medycznego w Lublinie +1 more
core
Efficacy of the first and subsequent courses of anti-TNF therapy in patients with ankylosing spondylitis - results from the Czech National Register ATTRA Skuteczność pierwszego i kolejnych kursów terapii anty-TNF u pacjentów z zesztywniającym zapaleniem s [PDF]
, 2012 S u m m a r y Background: Efficacy of switching of anti-tumour necrosis factor (anti-TNF) in ankylosing spondylitis (AS) in real clinical practice is not fully known.
Reu Ma, Gia Lo
core
Parasite genetic diversity does not influence TNF-mediated effects on the virulence of primary rodent malaria infections [PDF]
, 2006 The pro-inflammatory cytokine tumour necrosis factor alpha (TNF-alpha) is associated with malaria virulence (disease severity) in both rodents and humans.
Long, G H +19 more
core +1 more source
Miejsce oznaczeń poziomu przeciwciał anty-tyreoglobulinowych w diagnostyce autoimunologicznych chorób tarczycy [PDF]
, 2006 Tyroglobulin and thyroid peroxidase antibodies have been estimated in patients with thyroid autoimmune diseases. In a group of 109 patients with Hashimoto’s thyroidities 85.53% and 78.89% were positive for Tyroglobulin antibodies and anti-TPO ...
Jastrzębska-Bohaterewicz, Ewa; Zakład Biochemii Klinicznej, Centrum Medyczne Kształcenia Podyplomowego, Warszawa +2 more
core